Revlimid vs. Cyclophosphamide: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Revlimid and Cyclophosphamide. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 622,663 people who take Revlimid and Cyclophosphamide, and is updated regularly.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
622,663 people who take Revlimid and Cyclophosphamide are studied.
Drugs being compared in this study:
- Cyclophosphamide (cyclophosphamide)
- Revlimid (lenalidomide)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Revlimid:
- not at all: 2.81 %
- somewhat: 12.36 %
- moderate: 19.1 %
- high: 35.39 %
- very high: 30.34 %
Cyclophosphamide:
- not at all: 5.32 %
- somewhat: 26.6 %
- moderate: 30.85 %
- high: 24.47 %
- very high: 12.77 %
Want to compare Revlimid with Cyclophosphamide?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Related studies
Alternative drugs to, pros and cons of:
- Revlimid (377,738 reports)
- Cyclophosphamide (185,122 reports)
Browse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on lenalidomide and cyclophosphamide (the active ingredients of Revlimid and Cyclophosphamide, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tamsulosin and Rash Generalised for Women aged 50-59 - 25 seconds ago
- Tamsulosin and Rash for Women aged 50-59 - 26 seconds ago
- Tamsulosin and Skin Redness Or Inflammation for Women aged 50-59 - 26 seconds ago
- Tamsulosin and Skin Rash for Women aged 50-59 - 26 seconds ago
- Tamsulosin and Skin Lesion for Women aged 50-59 - 27 seconds ago
- Tamsulosin and Rubor for Women aged 50-59 - 27 seconds ago
- Tamsulosin and Erythema for Women aged 50-59 - 27 seconds ago
- Tamsulosin and Rashes for Women aged 50-59 - 28 seconds ago
- Could Pantoprazole cause Catheter Site Rash? - 33 seconds ago
- Drug interactions of Depakote Er and Flonase - 37 seconds ago